Labcorp Total Assets 2010-2023 | LH

Labcorp total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Labcorp total assets for the quarter ending December 31, 2023 were $16.886B, a 14.83% decline year-over-year.
  • Labcorp total assets for 2022 were $20.155B, a 1.13% decline from 2021.
  • Labcorp total assets for 2021 were $20.385B, a 1.56% increase from 2020.
  • Labcorp total assets for 2020 were $20.072B, a 11.22% increase from 2019.
Labcorp Annual Total Assets
(Millions of US $)
2022 $20,155
2021 $20,385
2020 $20,072
2019 $18,046
2018 $16,185
2017 $16,673
2016 $14,247
2015 $14,105
2014 $7,302
2013 $6,966
2012 $6,795
2011 $6,112
2010 $6,188
2009 $4,838
Labcorp Quarterly Total Assets
(Millions of US $)
2023-09-30 $16,886
2023-06-30 $17,719
2023-03-31 $20,200
2022-12-31 $20,155
2022-09-30 $19,826
2022-06-30 $20,403
2022-03-31 $20,728
2021-12-31 $20,385
2021-09-30 $20,867
2021-06-30 $20,417
2021-03-31 $20,417
2020-12-31 $20,072
2020-09-30 $18,740
2020-06-30 $17,849
2020-03-31 $17,298
2019-12-31 $18,046
2019-09-30 $17,848
2019-06-30 $17,744
2019-03-31 $16,971
2018-12-31 $16,185
2018-09-30 $16,661
2018-06-30 $16,505
2018-03-31 $16,832
2017-12-31 $16,673
2017-09-30 $16,692
2017-06-30 $14,903
2017-03-31 $14,428
2016-12-31 $14,247
2016-09-30 $14,483
2016-06-30 $14,199
2016-03-31 $14,410
2015-12-31 $14,105
2015-09-30 $14,422
2015-06-30 $14,465
2015-03-31 $14,151
2014-12-31 $7,302
2014-09-30 $7,232
2014-06-30 $7,145
2014-03-31 $6,992
2013-12-31 $6,966
2013-09-30 $6,687
2013-06-30 $6,592
2013-03-31 $6,569
2012-12-31 $6,795
2012-09-30 $6,814
2012-06-30 $6,098
2012-03-31 $6,131
2011-12-31 $6,112
2011-09-30 $6,053
2011-06-30 $6,168
2011-03-31 $6,202
2010-12-31 $6,188
2010-09-30 $5,048
2010-06-30 $4,958
2010-03-31 $4,934
2009-12-31 $4,838
2009-09-30 $4,830
2009-06-30 $4,713
2009-03-31 $4,828
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.310B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.527B 20.19
McKesson (MCK) United States $66.590B 17.82
West Pharmaceutical Services (WST) United States $25.910B 43.34
Cardinal Health (CAH) United States $25.629B 15.40
Align Technology (ALGN) United States $24.013B 47.58
Cooper (COO) United States $19.020B 29.91
Henry Schein (HSIC) United States $9.829B 14.98
DENTSPLY SIRONA (XRAY) United States $7.150B 18.24
Merit Medical Systems (MMSI) United States $4.617B 26.74
Patterson (PDCO) United States $2.632B 12.03
CONMED (CNMD) United States $2.500B 23.56
STAAR Surgical (STAA) United States $1.503B 68.42
Atrion (ATRI) United States $0.627B 29.47
Lifevantage (LFVN) United States $0.089B 14.42
Pro-Dex (PDEX) United States $0.061B 23.32
Biolase (BIOL) United States $0.001B 0.00